WASHINGTON (DC News Now) — In a major breakthrough, the Food and Drug Administration (FDA) recently approved the first two gene therapies for sickle cell disease. Doctors hope they can cure the painful, inherited blood disorder that afflicts mostly Black people in the U.S. The FDA said the one-time treatments can be used for patients 12 […]
Conference to convene gene- and cell-therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies
PISCATAWAY, N.J., Dec. 14, 2023.
AscellaHealth Identifies Key Trends Worth Watching in 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Qiagen (NYSE:QGEN – Get Free Report) and Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 58.0% of Qiagen shares […]